Articles dans des revues avec comité de lecture (144)
69.
Pierard, V., Guiguen, A., Colin, L., Wijmeersch, G., Vanhulle, C., Van Driessche, B., Dekoninck, A., Blazkova, J., Cardona, C., Merimi, M., Vierendeel, V., Calomme, C., Nguyen, T. L.-A., Nuttinck, M., Twizere, J.-C., Kettmann, R., Portetelle, D., Burny, A., Hirsch, I., Rohr, O., & Van Lint, C. (2010). DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: Potential involvement of direct inhibition of CREB/CREM/ATF transcription factor binding. The Journal of biological chemistry. doi:10.1074/jbc.M110.10760770.
Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., De Launoit, Y., Moutschen, M., Burny, A., Rouzioux, C., De Wit, S., Herbein, G., Rohr, O., Collette, Y., Lambotte, O., Clumeck, N., & Van Lint, C. (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PloS one, 4(6), e6093. doi:10.1371/journal.pone.000609371.
Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, D., Van Lint, C., Hejnar, J., & Hirsch, I. (2009). CpG methylation controls reactivation of HIV from latency. PLoS pathogens, 5(8), e1000554. doi:10.1371/journal.ppat.100055472.
Ndlovu, M. N., Van Lint, C., Van Wesemael, K., Callebert, P., Chalbos, D., Haegeman, G., & Vanden Berghe, W. (2009). Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Molecular and cellular biology, 29(20), 5488-5504. doi:10.1128/MCB.01657-0873.
Vire, B., De Walque, S., Restouin, A., Olive, D., Van Lint, C., & Collette, Y. (2009). Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions. PloS one, 4(9), e7085. doi:10.1371/journal.pone.000708574.
Le Van, K., Cauvin, C., De Walque, S., Georges, B., Boland, S., Martinelli, V., Demonte, D., Durant, F., Hevesi, L., & Van Lint, C. (2009). New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors. Journal of medicinal chemistry, 52(12), 3636-3643. doi:10.1021/jm801438e75.
Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G., Sawaya, B. E., Zeichner, S. L., Aunis, D., Van Lint, C., & Rohr, O. (2009). p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene, 28(38), 3380-3389. doi:10.1038/onc.2009.19376.
Vandurm, P., Cauvin, C., Guiguen, A., Georges, B., Le Van, K., Martinelli, V., Cardona, C., Mbemba, G., Mouscadet, J.-F., Hevesi, L., Van Lint, C., & Wouters, J. (2009). Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor. Bioorganic & medicinal chemistry letters, 19(16), 4806-4809. doi:10.1016/j.bmcl.2009.06.04478.
Mahlknecht, U., Dichamp, I., Varin, A., Van Lint, C., & Herbein, G. (2008). NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells. Journal of leukocyte biology, 83(3), 718-727. doi:10.1189/jlb.060740579.
Calao, M., Burny, A., Quivy, V., Dekoninck, A., & Van Lint, C. (2008). A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code. Trends in biochemical sciences, 33(7), 339-349. doi:10.1016/j.tibs.2008.04.01580.
Twizere, J.-C., Springael, J.-Y., Boxus, M., Burny, A., Dequiedt, F., Dewulf, J.-F., Duchateau, J., Portetelle, D., Urbain, P., Van Lint, C., Green, P. L., Mahieux, R., Parmentier, M., Willems, L., & Kettmann, R. (2007). Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling. Blood, 109(3), 1051-1060. doi:10.1182/blood-2006-06-026781